CCL vs EDIT · P/E 15, rev $25.02B vs rev $32.3M
Carnival Corporation (CCL) versus Editas Medicine Inc (EDIT) — a side-by-side from cached financials, not a winner call.
Carnival Corporation (CCL) is a travel services company listed on US.
Editas Medicine Inc (EDIT) is a biotechnology company listed on NASDAQ.
Latest reported CCL revenue for 2024-11-30 was $25.02B. Net income was $1.92B. Revenue was up 15.9% from 2023-11-30 to 2024-11-30. CCL currently screens at market cap $39.74B and trailing P/E 15.3.
Latest reported EDIT revenue for 2024-12-31 was $32.3M. Net income was -$237.1M. Revenue was down 58.6% from 2023-12-31 to 2024-12-31. EDIT currently screens at market cap $375.2M.
CCL currently screens at market cap $39.74B and trailing P/E 15.3. EDIT currently screens at market cap $375.2M.
Not investment advice. Open the CCL and EDIT stock pages for the full models.
Not investment advice.